9002-89-5 Usage
Air & Water Reactions
Water soluble.
Fire Hazard
This chemical is combustible. The dusts of this chemical are a slight explosion hazard when exposed to flame. (NTP, 1992)
Health Hazard
SYMPTOMS: Inhalation of the dust of this chemical may cause irritation of the nose and throat and cause coughing and chest discomfort if heated above 390° F. The dusts may also irritate the eyes. Implantation of this chemical into the breast has been associated with fibrosis.
ACUTE/CHRONIC HAZARDS: This compound may be harmful by ingestion and inhalation. It may cause irritation. When heated to decomposition it emits acrid smoke, irritating fumes and toxic fumes of carbon monoxide and carbon dioxide. (NTP, 1992)
Reactivity Profile
Mixtures of alcohols with concentrated sulfuric acid and strong hydrogen peroxide can cause explosions. Example: an explosion will occur if dimethylbenzylcarbinol is added to 90% hydrogen peroxide then acidified with concentrated sulfuric acid. Mixtures of ethyl alcohol with concentrated hydrogen peroxide form powerful explosives. Mixtures of hydrogen peroxide and 1-phenyl-2-methyl propyl alcohol tend to explode if acidified with 70% sulfuric acid [Chem. Eng. News 45(43):73. 1967; J, Org. Chem. 28:1893. 1963]. Alkyl hypochlorites are violently explosive. They are readily obtained by reacting hypochlorous acid and alcohols either in aqueous solution or mixed aqueous- carbon tetrachloride solutions. Chlorine plus alcohols would similarly yield alkyl hypochlorites. They decompose in the cold and explode on exposure to sunlight or heat. Tertiary hypochlorites are less unstable than secondary or primary hypochlorites [NFPA 491 M 1991]. Base-catalysed reactions of isocyanates with alcohols should be carried out in inert solvents. Such reactions in the absence of solvents often occur with explosive violence [Wischmeyer 1969].
Chemical properties
Polyvinyl alcohol is a hydrolysis product of polyvinyl acetate, rather than by the polymerization of monomers; the molecular backbone contains . The specific gravity of this product 1.25 to 1.35 and the melting point is 212 ~ 267 ℃. It is soluble in hot water and hot dimethyl sulfoxide. Animal experiments show that polyvinyl alcohol, without stimulation, causes no significant toxicity upon subcutaneous, intramuscular, intravenous injection. Polyvinyl alcohol resin products appear as white solid with the appearance of sub-floc, granular and powder; it is non-toxic, tasteless, non-polluting and is soluble in water of 80--90 ℃. Its aqueous solution has good adhesiveness and film-forming property; it can resist most organic solvents such as oils, lubricants and hydrocarbons; it has long-chain polyol esterification, etherification, acetalization and other chemical properties.
Uses
Different sources of media describe the Uses of 9002-89-5 differently. You can refer to the following data:
1. It is mainly used in the textile industry, as the raw materials of warp pulp, fabric finishing agent, vinylon fiber; interior and exterior wall paint of the building, adhesives; chemical industry use it as a polymerization emulsifier, dispersant and polyvinyl formal, acetal, butyrate aldehyde resin; paper industry use it as a paper binder; agriculture use it as soil improvers, pesticide adhesion synergist and polyvinyl alcohol film; it can also be used for daily cosmetics and high-frequency quenching agent and so on.
2. In the plastics industry in molding Compounds, surface coatings, films resistant to gasoline, textile sizes and finishing compositions; can be compounded to yield elastomers to be used in manufacture of artificial sponges, fuel hoses, etc., also in printing inks for plastics and glass, in pharmaceutical finishing, cosmetics, water-sol film and sheeting. Pharmaceutic aid (viscosity increasing agent); ophthalmic lubricant.
3. NaA zeolite particles have been dispersed in a poly(vinyl alcohol) matrix to prepare a mixed-matrix membrane to study the pervaporative separation of water-butanol mixtures. Poly (vinyl alcohol)/gelatin based biocompatible polymeric scaffolds have been used to design for 3D cancer models.
4. Mowiol? 40-88 can be used for a variety of applications such as drug delivery, surface enhanced Raman spectroscopy (SERS) fiber-optic sensors, and transparent conducting oxides (TCOs).
Chemical Properties
Polyvinyl alcohol occurs as an odorless, white to cream-colored
granular powder.
Preparation
Vinyl alcohol has not been isolated in the free state; the keto tautomer,
acetaldehyde, is much the more stable form and is always obtained:Thus poly(vinyl alcohol) cannot be prepared from its monomer by the usual
techniques, although the polymerization of acetaldehyde with sodium
amalgam at - 80 to - 20℃ has been found to give poly( vinyl alcohol) of low
molecular weight. For commercial purposes, poly(vinyl alcohol) is obtained exclusively from poly(vinyl acetate).Poly(vinyl acetate) is readily hydrolysed by treating an alcoholic solution
with aqueous acid or alkali. Acid hydrolysis results in traces of acid in the
poly(vinyl alcohol) which are difficult to remove and which lead to instability
of the polymer; alkaline hydrolysis results in contamination of the product by
a large amount of sodium acetate which is also difficult to remove and which
has little intrinsic value. These difficulties are avoided if poly(vinyl alcohol) is
prepared from poly(vinyl acetate) by alcoholysis using a small amount of base
as catalyst. The reaction is commonly carried out by treating poly(vinyl
acetate) with methanol in the presence of sodium methoxide:The preferred methods of preparing poly(vinyl acetate) for conversion to
poly(vinyl alcohol) are solution and suspension polymerization. The former
technique has the advantage that if polymerization is conducted in methanol
the resulting solution can be used directly without the need for isolating the
polymer; this method is the most suitable for continuous processes. Bulk
polymerized poly(vinyl acetate) tends to give low molecular weight poly(vinyl
alcohol) of poor colour.
In one continuous process, a solution of poly(vinyl acetate) in methanol
(about 20%) is mixed with the catalyst solution in a high speed in-line mixer.
The mixture then passes through a 'gelling zone' on a conveyor belt. Typically, the material is kept at 40℃ for 10 minutes in this zone during which
time the alcoholysis reaction occurs; poly(vinyl alcohol) is insoluble in
methanol and a gel is produced. The gel is chopped up and neutralized with
acetic acid to stop reaction; the liquid content (whica is mainly methanol and
methyl acetate) is then expressed and recovered. The residual solid is washed
with methanol, dried and pulverized.It is possible to control the extent to which acetate groups are replaced by
hydroxyl groups by changing the reaction conditions. In particular, the
catalyst concentration and the time of reaction have a major effect on the
degree of alcoholysis. The most common commercial types of poly(vinyl
alcohol) are the so-called partially hydrolysed grades in which 87-89% of the
acetate groups have been replaced and the completely hydrolysed grades in
which 99-100% of the acetate groups have been replaced. The degree of
alcoholysis has an effect on the properties of the polymer.
Definition
ChEBI: A homopolymer macromolecule obtained by polymerisation of vinyl alcohol.
Production Methods
Polyvinyl alcohol is produced through the hydrolysis of polyvinyl
acetate. The repeating unit of vinyl alcohol is not used as the starting
material because it cannot be obtained in the quantities and purity
required for polymerization purposes. The hydrolysis proceeds
rapidly in methanol, ethanol, or a mixture of alcohol and methyl
acetate, using alkalis or mineral acids as catalysts.
Brand name
Liquifilm Tears (Allergan).
General Description
Polyvinyl alcohol (PVOH) is a hydrophilic linear polymer which forms copolymers of vinyl alcohol and vinyl acetate. Hence, the structural properties of polyvinyl alcohol polymers depend on the extent of polymerization and hydrolysis. Such changes cause both chemical and physical modifications such as esterification, etherification, crystallization, ion-polymer complexation in the polymer. Modified- PVOH structures are useful in biomedical applications.
Pharmaceutical Applications
Polyvinyl alcohol is used primarily in topical pharmaceutical and
ophthalmic formulations. It is used as a stabilizing
agent for emulsions (0.25–3.0% w/v). Polyvinyl alcohol is also used
as a viscosity-increasing agent for viscous formulations such as
ophthalmic products. It is used in artificial tears and contact lens
solutions for lubrication purposes, in sustained-release formulations
for oral administration, and in transdermal patches. Polyvinyl
alcohol may be made into microspheres when mixed with a
glutaraldehyde solution.
Industrial uses
Polyvinyl alcohol is a tough, whitish polymerthat can be formed into strong films, tubes, andfibers that are highly resistant to hydrocarbonsolvents. Although polyvinyl alcohol is one ofthe few water-soluble polymers, it can be renderedinsoluble in water by drawing or by theuse of cross-linking agents.
Biochem/physiol Actions
Poly(vinyl alcohol) (PVA) is a polyhydroxy polymer, soluble in water. PVA is known to possess high mechanical strength, biocompatibility and non-toxicity. Hence, it serves as a biomedical implant material. Polymerization of vinyl acetate to poly (vinyl acetate), which is then hydrolysed to form PVA. Its application is observed in drug delivery systems, wound dressing, dialysis membranes, artificial skin, surgical repairs and cardiovascular devices.
Safety Profile
Questionable
carcinogen with experimental carcinogenic
and tumorigenic data by implant route.
Flammable when exposed to heat or flame;
can react with oxidizing materials. Slight
explosion hazard in the form of dust when
exposed to flame. To fight fire, use alcohol
foam, CO2, dry chemical. When heated to
decomposition it emits acrid smoke and
irritating fumes.
Safety
Polyvinyl alcohol is generally considered a nontoxic material. It is
nonirritant to the skin and eyes at concentrations up to 10%;
concentrations up to 7% are used in cosmetics.
Studies in rats have shown that polyvinyl alcohol 5% w/v
aqueous solution injected subcutaneously can cause anemia and
infiltrate various organs and tissues.
(mouse, oral): 14.7 g/kg
(rat, oral): >20 g/kg
storage
Polyvinyl alcohol is stable when stored in a tightly sealed container
in a cool, dry place. Aqueous solutions are stable in corrosionresistant
sealed containers. Preservatives may be added to the
solution if extended storage is required. Polyvinyl alcohol undergoes
slow degradation at 100°C and rapid degradation at 200°C; it
is stable on exposure to light.
Incompatibilities
Polyvinyl alcohol undergoes reactions typical of a compound with
secondary hydroxy groups, such as esterification. It decomposes in
strong acids, and softens or dissolves in weak acids and alkalis. It is
incompatible at high concentration with inorganic salts, especially
sulfates and phosphates; precipitation of polyvinyl alcohol 5% w/v
can be caused by phosphates. Gelling of polyvinyl alcohol solution
may occur if borax is present.
Regulatory Status
Included in the FDA Inactive Ingredients Database (ophthalmic
preparations and oral tablets). Included in nonparenteral medicines licensed in the UK. Included in the Canadian List of Acceptable
Non-medicinal Ingredients.
Check Digit Verification of cas no
The CAS Registry Mumber 9002-89-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 9,0,0 and 2 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 9002-89:
(6*9)+(5*0)+(4*0)+(3*2)+(2*8)+(1*9)=85
85 % 10 = 5
So 9002-89-5 is a valid CAS Registry Number.
9002-89-5Relevant articles and documents
Process for Producing Perfluoropolyether Carboxylic Acid Fluoride
-
Page/Page column 3, (2009/04/24)
Perfluoropolyether carboxylic acid fluoride having the following general formula: [in-line-formulae]F(CF2CF2CF2O)nCF2CF2COF[/in-line-formulae](n: 2-200, preferably 35-70) can be produced by starting fluorination reaction of polyfluoropolyether carboxylic acid having the general formula as a tetrafluorooxetane polymer: [in-line-formulae]F(CH2CF2CF2O)nCH3CF2COF[/in-line-formulae](n: 2-200) in a dispersed state in a perfluoropolyether-based solvent with a fluorine gas at 50° -80° C. , then slowly elevating the fluorination reaction temperature, and finally completing the fluorination reaction at 100°-120° C., where even in the case of fluorination reaction of the starting material with a high degree of polymerization the desired product can be produced in high yield, while suppressing the decomposition and keeping the high degree of polymerization substantially.
Pharmaceutical composition intended in particular for the prevention and the treatment of radiomucositis and chemomucositis
-
, (2008/06/13)
The invention concerns a pharmaceutical composition designed to adhere to a mucous membrane for preventing or treating radiotherapy-related and chemotherapy-related mucositis, induced by radiotherapy or combined radiochemotherapy, comprising an effective amount of an antiradical compound mixed with a vehicle, which is liquid at room temperature and gels at the mucous membrane temperature and capable of adhering to the mucous membrane by its gelled status.
Bdellosomes
-
, (2008/06/13)
The invention relates to solid particles for transportation of pharmaceutically active substances, to processes for the preparation thereof, to medicinal drugs containing said particles, and to the use of said particles for various specific indications.
Dressing based on the Teorell-Meyer gradient
-
, (2008/06/13)
A dressing designed in consideration of Teorell-Meyer gradients is described. This dressing delivers, either individually, or seriatim, pharmaceutically effective amounts of drugs and therapeutic ions to a wound site.
Preventives/remedies for alzheimer's disease
-
, (2008/06/13)
The present invention provides an agent for the prophylaxis or treatment of Alzheimer's disease. The agent for the prophylaxis or treatment of Alzheimer's disease of the present invention containing a compound having a GnRH antagonistic action shows low toxicity and has a superior preventive and therapeutic effect on Alzheimer's disease.
Application of film forming technology to fragrance control release systems; and resultant fragrance control release systems
-
, (2008/06/13)
Described is a fragrance control release system which is an emulsifier-free, single phase, nonporous, continuous, permeable polymeric film having a substantially uniform thickness of from about 1 up to about 150 microns, having entrapped and dissolved therein molecules of at least one fragrance substance capable of evolving from said film into the environment proximate said film by means of molecular diffusion at a permeation rate of from about 1×10-7 up to about 0.1 mg-mm/cm2 -min in a sustained and controlled release manner. Also described is a process for using the aforementioned system for imparting a fragrance into the environment above the unobstructed outer surface of the aforementioned polymer film which is coated on the surface of a solid or semi-solid support, e.g., a solid surface or human epidermis.
Use of sustained release antibiotic compositions in ophthalmic surgical procedures
-
, (2008/06/13)
An improved method of sterilizing the field of surgery prior to an ophthalmic surgical procedure is described. The invention eliminates the need for painful and potentially traumatic injections of antibiotics by utilizing sustained release compositions which allow the antibiotics contained therein to penetrate deeply into the eye, thereby ensuring a sterile field of surgery during intraocular surgical procedures. The compositions may also be utilized to prevent post-surgical infections.
Compositions which contain active substances and are in the form of solid particles
-
, (2008/06/13)
Compositions which contain active substances and are in the form of solid particles can be obtained by intimately mixing the active substance with a water-soluble melt composed of a) 10-90% by weight of a water-soluble polymer A with a viscosity Va of 1,000-120,000 cps and b) 10-90% by weight of a water-soluble polymer B with a viscosity Vb of 1-500 cps as carrier substance, where the viscosities Va and Vb are those of a 2% by weight aqueous solution at 20° C., measured by the ASTM D 2363-72 capillary method (European Pharmacopoeia, Vol. III, p. 37), and processing the melt with shaping to give the particles.
Process for the protection of plant seeds and apparatus to carry out said process
-
, (2008/06/13)
An improved process for the phytoprotection of plant seeds, wherein there is simultaneously applied to the seeds, on the one hand, at least one first liquid composition containing at least one phytoprotection product, and on the other hand, a foam formed from a second composition, containing at least one nonphytotoxic foaming agent.
